Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Evans
OPSIS, NCT05665387: Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia	Completed	2	79	US	0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo	Santen Inc.	Presbyopia	07/23	07/23
TG4050.02, NCT04183166: A Clinical Trial Evaluating TG4050 in Head and Neck Cancer	Recruiting	1/2	80	Europe, US	TG4050	Transgene	Squamous Cell Carcinoma of Head and Neck	12/27	12/28